Please upgrade your browser.
NEW YORK July 24, 2008 Patients treated for kidney cancer that has spread to other organs live longer without the cancer advancing when treated with a new drug, researchers say. The new drug is called everolimus and the study led by Dr. Robert Motzer, of Memorial Sloan-Kettering Cancer Center, showed that the drug prolongs progression-free survival relative to placebo in patients who have experienced treatment failure on other regimens. The results of the study appear yesterday in an early online edition of The Lancet. Source: Cancerfacts.com
BOSTON A growth on a kidney removed from conductor James Levine was malignant, but the cancer was caught early and no further treatment is needed, the Boston Symphony Orchestra said Tuesday. Source: Foxnews.com
People in North America, Western Europe and other developed countries do better than people from Africa.
Dying patient was told he must pay for free medicine.
"It was a miracle," said Rooney, of Mountain Brook, Ala., who is recovering from a June 23 operation in which a surgeon removed a cancerous kidney tumor about the size of an orange.
His success on the field has allowed him to bring a lot of excitement and smiles off the field to children battling cancer.
A GRANDMOTHER who took her fight for a cancer drug to the High Court is today in hospital struggling to breathe.
Anti-rejection drugs given after organ transplants may be the reason why 15 percent to 20 percent of individuals who receive such transplants have a higher risk of developing cancer within the next decade.
AUSTRALIAN fashion designer Mark Keighery has lost his long and courageous fight with cancer. The founder of Marcs clothing empire succumbed to the serious infection, septacaemia, following his latest operation to stave off the disease last month. Source: The Daily Telegraph (online)
The cases of microangiopathic hemolytic anemia seen in a Phase 1 kidney cancer study led to the closure of a mid-stage trial of Avastin plus Sutent, Genentech said in a letter to doctors that was posted on the Food and Drug Administration's website.
|Powered by NeonCRM|